Actividades asistenciales
INHIBIDORES DE LA PROTEÍNA TIROSINA FOSFATASA
24/09/2021 -
Se proporcionan compuestos de la Fórmula <strong>I</strong> o un estereoisómero, tautómero, profármaco o sal aceptable desde el punto de vista farmacéutico de...
Pharmaceutical composition for treatment or prophylaxis of anhedonia
16/12/2025 -
The present invention provides a pharmaceutical composition for treatment or prophylaxis of anhedonia, which contains a selective [delta] opioid receptor agonist as an active ingredient,...
RNA inhibitors for inhibiting insulin-lke growth factor 1 receptor expression
01/12/2025 -
The present application relates to an RNA inhibitor for inhibiting the expression of insulin-like growth factor 1 receptor (IGF-1R) comprising an antisense strand, said antisense strand forming a...
Compounds and compositions for treating conditions associated with calcitonin receptor and/or amylin receptor activity
01/12/2025 -
The present disclosure provides compounds for modulating calcitonin receptor and/or amylin receptor activity, as well as pharmaceutical compositions comprising the compounds disclosed herein. Also...
Quinazoline compound and pharmaceutical
16/12/2025 -
The present invention provides a quinazoline compound having inhibitory activity of mPGES-1, which is represented by the general formula [1]: (wherein, R1is -NR6R7, alkoxy, cycloalkyl or alkyl; R2...
MASP-2 MASP-2 INHIBITORS AND METHODS OF USE
26/02/2026
Nucleic acid molecules and uses thereof for non-viral gene therapy
16/12/2025 -
The present disclosure provides nucleic acid molecules comprising a first inverted terminal repeat (ITR), a second ITR, and a genetic cassette encoding a target sequence. In some embodiments, the...
用于治疗由毒蕈碱受体激活所缓解的障碍的组合物和方法
10/03/2026 -
...
用于治疗神经学疾病或病症的新型治疗方法
10/03/2026 -
...
大麻二酚对自闭症谱系障碍的治疗
10/03/2026 -
...
ストレス調節用組成物および方法ならびにその使用
06/03/2026 -
...
RIP1K RIP1K INHIBITORS
20/02/2026 -
키나제 억제 화합물, 예컨대 수용체-상호작용 단백질-1 (RIP1) 키나제 억제제 화합물, 뿐만 아니라 이러한 억제 화합물을 포함하는 제약 조성물 및...
DERIVATIVES OF SUBSTITUTED MORPHOLINES AND USES THEREOF
20/02/2026 -
화학식 I의 화합물은 이의 입체이성질체 및/또는 이의 염을 포함하되; R1은 치환된 알칸기, 복소환식기 또는 피리딘기이고; X는 수소, 할로겐,...
用于治疗高胱氨酸尿症的胱硫醚β-合酶
10/03/2026 -
...
Aqueous oil-resistant agent composition, method for producing aqueous oil-resistant agent composition, method for oil resistance treatment for paper, and oil-resistant paper
01/12/2025 -
To provide a non-fluorinated resin-based aqueous oil-resistant agent composition with which oil-resistant paper having high oil resistance and high air permeability can be obtained, the components...
检查方法
10/03/2026 -
...
MÉTODOS PARA EL TRATAMIENTO DE ENFERMEDADES RELACIONADAS CON TNFA
30/11/2020 -
La presente invención se refiere a métodos para el tratamiento de una enfermedad relacionada con TNF-α mediante la administración subcutánea de un anticuerpo que se une a TNF-α (anticuerpo...
APPARATUS AND METHOD FOR ASSISTING MUSCULAR STRENGTH
06/03/2026 -
...
生理参数的解剖位置标记
10/03/2026 -
...
ラボラトリサンプルをラベル付け及び追跡する、システム、方法、及び装置
06/03/2026 -
...
Actividades asistenciales
Agroalimentación
Automoción y nueva movilidad
Energía sostenible y eficiente
Materiales avanzados
Medio ambiente y sostenibilidad
Patrimonio natural y cultural
Procesos productivos e industria 4.0
Química y biotecnología
Salud y calidad de vida
Transformación digital



